This is a preview of subscription content, log in via an institution to check access.
Notes
probability sensitivity analysis
Reference
Tai T-A, et al. Prevalence of Immature Survival Data for Anti-Cancer Drugs Presented to the National Institute for Health and Care Excellence and Impact on Decision Making. Value in Health : 8 Dec 2020. Available from: URL: https://doi.org/10.1016/j.jval.2020.10.016
Rights and permissions
About this article
Cite this article
Immature survival data for cancer drugs impacts NICE decisions. PharmacoEcon Outcomes News 869, 16 (2021). https://doi.org/10.1007/s40274-021-7383-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7383-y